CeQur has raised $100.0M in Series E funding. The Horw, Switzerland-based medical device company makes a wearable insulin patch called CeQur Simplicity, a discreet, injection-free device worn on the body to deliver mealtime insulin for people with type 1 and type 2 diabetes.
The company, which runs its US operations out of Greenville, South Carolina, positions the patch as a way to help users stick to their insulin regimen and keep blood glucose in check.
















